臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"jia horng kao"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 421-470 of 1180 (24 Page(s) Totally)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-09-04T06:11:44Z	Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: A nationwide cohort study	Huang Y.-W.; Wang T.-C.; Lin S.-C.; Chang H.-Y.; Chen D.-S.; Hu J.-T.; Yang S.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:43Z	Factors affecting the diagnostic accuracy of ultrasonography in assessing the severity of hepatic steatosis	Wang C.-C.; Hsieh T.-C.; Tseng T.-C.; Wang P.-C.; Hsu C.-S.; Lin H.H.; Wang L.-Y.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:43Z	Hepatic necro-inflammation and elevated liver enzymes: Evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients	Chen B.-B.; Hsu C.-Y.; Yu C.-W.; JIA-HORNG KAO; Lee H.-S.; Liang P.-C.; Wei S.-Y.; Hwang R.-M.; Shih T.T.-F.
臺大學術典藏	2021-09-04T06:11:43Z	Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy	Su T.-H.; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:42Z	Vascular and hepatic enhancements at MR imaging: Comparison of Gd-EOB-DTPA and Gd-DTPA in the same subjects	Lin Y.-H.; Hwang R.-M.; Chen B.-B.; Hsu C.-Y.; Yu C.-W.; JIA-HORNG KAO; Lee H.-S.; Liang P.-C.; Wei S.-Y.; Shih T.T.F.
臺大學術典藏	2021-09-04T06:11:42Z	Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin	Chen M.-Y.; Liu C.-H.; Chen T.-C.; Su T.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO; Liu C.-J.
臺大學術典藏	2021-09-04T06:11:42Z	Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-na?ve Taiwanese patients with chronic hepatitis B	Chien R.-N.; Peng C.-Y.; JIA-HORNG KAO; Hu T.-H.; Lin C.-C.; Hu C.-T.; Chen C.-Y.; Hsieh T.-Y.; Lin H.-C.; Chuang W.-L.
臺大學術典藏	2021-09-04T06:11:41Z	Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters	Tseng T.-C.; Liu C.-J.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:41Z	Peginterferon α in the treatment of chronic hepatitis B	Tseng T.-C.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:11:40Z	Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: A prospective study in Taiwan	Chen C.-L.; Yang W.-S.; Yang H.-I.; Chen C.-F.; You S.-L.; Wang L.-Y.; Lu S.-N.; Liu C.-J.; JIA-HORNG KAO; Chen P.-J.; Chen D.-S.; Chen C.-J.
臺大學術典藏	2021-09-04T06:11:40Z	Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications	Wu H.-L.; JIA-HORNG KAO; Chen T.-C.; Wu W.-H.; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen D.-S.; Chen P.-J.; Liu C.-J.
臺大學術典藏	2021-09-04T06:11:40Z	Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously	Cheng H.-R.; JIA-HORNG KAO; Wu H.-L.; Chen T.-C.; Tseng T.-C.; Liu C.-H.; Su T.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.
臺大學術典藏	2021-09-04T06:11:39Z	All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: A multinational, phase 3, multicohort study	Manns M.; Pol S.; Jacobson I.M.; Marcellin P.; Gordon S.C.; Peng C.-Y.; Chang T.-T.; Everson G.T.; Heo J.; Gerken G.; Yoffe B.; Towner W.J.; Bourliere M.; Metivier S.; Chu C.-J.; Sievert W.; Bronowicki J.-P.; Thabut D.; Lee Y.-J.; JIA-HORNG KAO; McPhee F.; Kopit J.; Mendez P.; Linaberry M.; Hughes E.; Noviello S.
臺大學術典藏	2021-09-04T06:11:39Z	Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: A nationwide cohort study	Huang Y.-W.; Yang S.-S.; Fu S.-C.; Wang T.-C.; Hsu C.-K.; Chen D.-S.; Hu J.-T.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:38Z	HBeAg-positive chronic hepatitis B: Why do I treat my patients with pegylated interferon?	JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:38Z	A pilot study of add-on oral hypoglycemic agents in treatment-na?ve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin	Hsu C.-S.; Hsu S.-J.; Lin H.H.; Tseng T.-C.; Wang C.-C.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:38Z	Baseline hepatitis B surface antigen quantitation can predict virologic response in entecavir-treated chronic hepatitis B patients	Wang C.-C.; Tseng T.-C.; Wang P.-C.; Lin H.H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:38Z	Reduced toll-like receptor 9 expression on peripheral C D14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy	Huang Y.-W.; Hsu C.-K.; Lin S.-C.; Wei S.-C.; Hu J.-T.; Chang H.-Y.; Liang C.-W.; Chen D.-S.; Chen P.-J.; Hsu P.-N.; Yang S.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:37Z	Molecular mechanism and treatment of viral hepatitis-related liver fibrosis	Su T.-H.; JIA-HORNG KAO; Liu C.-J.
臺大學術典藏	2021-09-04T06:11:37Z	Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: Optimizing use of peginterferon alfa	Liu C.-H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:37Z	Triple therapy for hepatitis C virus infection in patients receiving hemodialysis	Liu C.-H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:36Z	Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: Molecular mechanisms and clinical significance	Yang H.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:36Z	Risk stratification of HBV infection in Asia-Pacific region	JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:36Z	The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo	Lin S.-R.; Yang H.-C.; Kuo Y.-T.; Liu C.-J.; Yang T.-Y.; Sung K.-C.; Lin Y.-Y.; Wang H.-Y.; Wang C.-C.; Shen Y.-C.; Wu F.-Y.; JIA-HORNG KAO; Chen D.-S.; Chen P.-J.
臺大學術典藏	2021-09-04T06:11:35Z	What can we learn from hepatitis B virus clinical cohorts?	Lin C.-L.; Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:35Z	Hepatitis B virus infection and metabolic syndrome: Fact or fiction?	Wang C.-C.; Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:35Z	Asunaprevir-containing regimens for the treatment of hepatitis C virus infection	Yang S.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:34Z	Viral hepatitis: HBV cure-can we pin our hopes on immunotherapy?	Yang H.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:34Z	Treating immune-tolerant Hepatitis B	Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:34Z	Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stages	Liu C.-J.; Chen T.-C.; Chen P.-J.; Wang H.-Y.; Tseng T.-C.; Cheng H.-R.; Liu C.-H.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:33Z	Hepatitis B virus genotypes and variants	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:33Z	Hepatitis B vaccination and prevention of hepatocellular carcinoma	JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:33Z	Reimbursement policies in the Asia-Pacific for chronic hepatitis B	Lim S.G.; Amarapurkar D.N.; Chan H.L.-Y.; Crawford D.H.; Gane E.J.; Han K.-H.; Ahn S.H.; Jafri W.; Jia J.; JIA-HORNG KAO; Lesmana L.A.; Lesmana C.R.A.; Mohamed R.; Phiet P.H.; Piratvisuth T.; Sarin S.K.; Sollarno J.D.; Eguchi Y.; Mahtab M.-A.; Lee K.H.
臺大學術典藏	2021-09-04T06:11:32Z	Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis B	Lin C.-L.; Liu C.-H.; Wang C.-C.; Liang C.-C.; Su T.-H.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:32Z	Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan	Chen C.-L.; Yang J.-Y.; Lin S.-F.; Sun C.-A.; Bai C.-H.; You S.-L.; Chen C.-J.; JIA-HORNG KAO; Chen P.-J.; Chen D.-S.
臺大學術典藏	2021-09-04T06:11:31Z	On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy	Huang Y.-W.; Takahashi S.; Tsuge M.; Chen C.-L.; Wang T.-C.; Abe H.; Hu J.-T.; Chen D.-S.; Yang S.-S.; Chayama K.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:31Z	Perspectives and control of hepatitis B virus infection in Taiwan	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:31Z	Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients	Wang C.-C.; Liu C.-H.; Lin C.-L.; Wang P.-C.; Tseng T.-C.; Lin H.H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:30Z	Reply to: Modulation of Toll-like receptor 9 expression on monocytes of viral hepatitis patients	Huang Y.-W.; Yang S.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:30Z	Successful treatment of chronic hepatitis B and D with pegylated-interferon plus entecavir	Chen G.-Y.; Su T.-H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:30Z	Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection	Cheng H.-R.; JIA-HORNG KAO; Wu H.-L.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Su T.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.
臺大學術典藏	2021-09-04T06:11:29Z	New insights into the evolutionary rate of hepatitis B virus at different biological scales	Lin Y.-Y.; Liu C.; Chien W.-H.; Wu L.-L.; Tao Y.; Wu D.; Lu X.; Hsieh C.-H.; Chen P.-J.; Wang H.-Y.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:11:29Z	Treating Immune-tolerant Hepatitis B	Tseng, T.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:29Z	Improving clinical outcomes of chronic hepatitis B virus infection	Su T.-H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:28Z	Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection	Song L.-W.; Liu P.-G.; Liu C.-J.; Zhang T.-Y.; Cheng X.-D.; Wu H.-L.; Yang H.-C.; Hao X.-K.; Yuan Q.; Zhang J.; JIA-HORNG KAO; Chen D.-S.; Chen P.-J.; Xia N.-S.
臺大學術典藏	2021-09-04T06:11:28Z	Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection	Hsu C.-S.; Liu W.-L.; Chao Y.-C.; Lin H.H.; Tseng T.-C.; Wang C.-C.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:28Z	HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients	Peng C.-Y.; Hsieh T.-C.; Hsieh T.-Y.; Tseng K.-C.; Lin C.-L.; Su T.-H.; Tseng T.-C.; Lin H.H.; Wang C.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:27Z	Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping	Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:27Z	Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy	Liang C.-C.; Liu C.-H.; Chung C.-S.; Lin C.-K.; Su T.-H.; Yang H.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:27Z	Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection	Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang W.-T.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO

Showing items 421-470 of 1180 (24 Page(s) Totally)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| Total items :0
	Visitors : 51519677 Online Users : 858 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library